Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy-Reference-Cited by-同舟云学术

Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

Published:2020-02-27 Issue:4 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Peluso Michael J.^ORCID,Bacchetti Peter^ORCID,Ritter Kristen D.,Beg Subul,Lai Jun,Martin Jeffrey N.^ORCID,Hunt Peter W.,Henrich Timothy J.,Siliciano Janet D.,Siliciano Robert F.^ORCID,Laird Gregory M.^ORCID,Deeks Steven G.^ORCID

Funder

UCSF/Gladstone Institute of Virology & Immunology CFAR

CFAR Network of Integrated Systems

Delaney AIDS Research Enterprise

amfAR Institute for HIV Cure Research

I4C Collaboratory

Beat-HIV Collaboratory

Gilead

Bill and Melinda Gates Foundation

NIAID

National Institutes of Health

National Science Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/132997/files/pdf

Reference38 articles.

1. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

2. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

3. Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

4. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

5. International AIDS Society global scientific strategy: towards an HIV cure 2016

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent Cocaine Use is Associated With Larger HIV Latent Reservoir Size;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

2. Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapy;eLife;2024-09-09

3. Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapy;eLife;2024-09-09

4. In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA);The Journal of Infectious Diseases;2024-09-03

5. Galectin 9 Levels as a Potential Predictor of Intact HIV Reservoir Decay;The Journal of Infectious Diseases;2024-08-28